C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2004
11/04/2004	US20040220111 administering polypeptide in mixturte with carrier; topical applying surface of body; wound healing agents; tissue repair
11/04/2004	US20040220097 Drug screening for compounds that modulate the function of anti-apoptotic protein Bcl-2 to induce apoptosis; identifying antitumor agents
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004	US20040219667 Monoclonal antibody for human telomerase catalytic subunit
11/04/2004	US20040219643 Dual-specific ligand
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy
11/04/2004	US20040219637 Soluble recombinant botulinum toxins having a C-terminal portion of a heavy chain, a N-terminal portion of a heavy chain and a light chain
11/04/2004	US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004	US20040219633 Method of producing recombinant antibodies
11/04/2004	US20040219632 T1r3 a novel taste receptor
11/04/2004	US20040219621 Test methods and devices
11/04/2004	US20040219614 Produced from a hybridoma prepared by fusing a mouse spleen and myeloma cell; detecting tumors; kits
11/04/2004	US20040219598 Immunoglobulin which recognizes multiple antigenic peptides (MAP) for use in the diagnosis and differentiation between glandular and bone disorders
11/04/2004	US20040219591 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
11/04/2004	US20040219575 Using presence of transcription factor/tumor antigen splice variant to diagnose cell proliferative disorders; tumor cell characterization
11/04/2004	US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004	US20040219521 Nucleotide sequences for use as tools in disease diagnostics, forensics, gene mapping, mutation identification and to assess biodiversity
11/04/2004	US20040219510 Assay method for group transfer reactions
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219163 Cell of vector that encodes the antigen
11/04/2004	US20040219162 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
11/04/2004	US20040219155 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases
11/04/2004	US20040219154 Monoclonal antibodies directed against hepatitis b viruses
11/04/2004	US20040219152 Methods for modulating angiogenesis with apelin compositions
11/04/2004	US20040219151 Tetraspan protein and uses thereof
11/04/2004	US20040219149 especially by administering an IL-9 antagonist such as a monoclonal, chimeric or humanized antibody or a soluble IL-9 receptor protein; treating asthma via bronchial administration with an aerosol inhaler; identifying an agent which modulates IL-13 expression
11/04/2004	US20040219147 administering an anti-inflammatory compound, especially an antibody to a complement component or an NSAID, to a subject receiving a stent in connection with percutaneous transluminal coronary angioplasty.
11/04/2004	US20040219146 Prevention and treatment of amyloidogenic disease
11/04/2004	US20040219145 Compositions and methods to modulate immune and inflammatory responses
11/04/2004	US20040219144 administering an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo, wherein said antibody has no significant adverse effect on the immune system
11/04/2004	US20040219143 immunotherapy, especially for treating autoimmune or atopic diseases, by administering recombinant Fc fragments, particularly of immunoglobulin G.
11/04/2004	US20040219142 Treatment of skin and nail disorders using TNFalpha inhibitors
11/04/2004	US20040219096 Enhancing interferon gamma production using interleukin 27; treating immune and proliferative disorders
11/04/2004	CA2823468A1 Compositions and methods for the therapy of inflammatory bowel disease
11/04/2004	CA2526914A1 Compositions and methods relating to stop-1
11/04/2004	CA2526887A1 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004	CA2523452A1 Cancer specific monoclonal antibodies
11/04/2004	CA2523244A1 Tissue factor antibodies and uses thereof
11/04/2004	CA2523142A1 Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
11/04/2004	CA2522957A1 Compositions and methods for the therapy of inflammatory bowel disease
11/04/2004	CA2522819A1 Polyvalent protein complex
11/04/2004	CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	CA2522670A1 Polypeptides related to natriuretic peptides and methods of their identification and use
11/04/2004	CA2522649A1 Treatment of conditions involving amyloid plaques
11/04/2004	CA2522086A1 Clostridium difficile focussed antibodies
11/04/2004	CA2521210A1 Methods for monitoring drug activities in vivo
11/04/2004	CA2520097A1 Truncated baff receptors
11/04/2004	CA2519563A1 Cytokine-expressing cellular vaccine combinations
11/03/2004	EP1473367A1 Means and methods for diagnosing and treating affective disorders
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472378A2 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472287A1 Rhamnose binding protein
11/03/2004	EP1472285A2 Secretory molecules
11/03/2004	EP1472281A1 Gene conferring resistance to phytophthera infestans (late-blight) in solanaceae
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472275A2 Protein purification
11/03/2004	EP1472274A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	EP1471929A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2004	EP1434871A4 Selection of cells expressing heteromeric polypeptides
11/03/2004	EP1228087A4 Antibody catalysis of enantio- and diastereo-selective aldol reactions
11/03/2004	EP1206494B1 Computational design methods for making molecular mimetics
11/03/2004	EP1071400B1 Drug delivery of proteins from polymeric blends
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	EP0594843B1 Antibody assay for amylin
11/03/2004	CN1543571A Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment
11/03/2004	CN1543569A Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
11/03/2004	CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004	CN1543505A Novel amylases and uses thereof
11/03/2004	CN1543474A T1R taste receptors and genes encoding same
11/03/2004	CN1543355A Immunogen adherence and method of making and using same
11/03/2004	CN1542132A Highly expressed recombinant virus containing human constant region all-antibody gene and its use for treating tumor
11/03/2004	CN1542020A Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof
11/03/2004	CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004	CN1174248C Graphitic nanotube for electrochemiluminescent detection , its composition ,detection agent and detection method thereof
11/03/2004	CN1174099C Nucleic acid vaccines encoding G protein of respiratory syncytial virus
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173740C Passively administered antibody that enhances feed conversion efficiency
11/03/2004	CN1173736C Use of interleukin-18 inhibitors in inhibiting tumor metastasis
11/03/2004	CN1173735C Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease
11/02/2004	US6812335 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
11/02/2004	US6812329 Construction and characterization of monoclonal antibodies against western equine encephalitis virus
11/02/2004	US6812327 Neutrokine-alpha polypeptides
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812210 Urocortin-III and uses thereof
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812024 Immunization of preferential animal; obtain animal, inject with antigen, allow for formation of antibodies, recover antibodies
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof

1 ... 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 ... 1494